Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as a promising alternative to redo conventional aortic valve replacement (cAVR). However there are concerns surrounding the efficacy and safety of VIV. This systematic review aims to compare the outcomes and safety of transcatheter VIV implantation with redoes cAVR. Six databases were systematically searched. A total of 18 relevant studies (823 patients) were included. Pooled analysis demonstrated VIV achieved significant improvements in mean gradient (38 mmHg preoperatively to 15.2 mmHg postoperatively, P<0.001) and peak gradient (59.2 to 23.2 mmHg, P=0.0003). These improvements were similar to the outcomes achieved by cAVR. The incidence of mo...
Objective: To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-T...
OBJECTIVES: Transcatheter aortic valve replacement (TAVR) represents a valid treatment for patients ...
International audienceBACKGROUND Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) ...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Objective. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a useful...
While redo surgical aortic valve replacement has traditionally been the gold standard for the treatm...
Introduction: The comparative efficacy and safety of valve-in-valve transcatheter aortic valve repla...
Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is an a...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
Objective: To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-T...
OBJECTIVES: Transcatheter aortic valve replacement (TAVR) represents a valid treatment for patients ...
International audienceBACKGROUND Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) ...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
Transcatheter valve-in-valve (VIV) implantation for degenerated aortic bioprostheses has emerged as ...
International audienceIntroduction Despite limited to short and midterm outcomes, valve-in-valve (Vi...
Objective. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a useful...
While redo surgical aortic valve replacement has traditionally been the gold standard for the treatm...
Introduction: The comparative efficacy and safety of valve-in-valve transcatheter aortic valve repla...
Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) for a failing prosthesis is an a...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
Objective: To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-T...
OBJECTIVES: Transcatheter aortic valve replacement (TAVR) represents a valid treatment for patients ...
International audienceBACKGROUND Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) ...